Silencing PCCA Suppresses Colorectal Cancer Growth and Spread
Author Information
Author(s): Zhang Chuyi, Zheng Zhinan, Wang Huaiming, Qi Ziwei, Wang Ying, Gao Zhunyi, Huang Yuhui, Jin Sanqing
Primary Institution: The Sixth Affiliated Hospital, Sun Yat-sen University
Hypothesis
PCCA could be a novel target to control colorectal cancer progression.
Conclusion
Knockdown of PCCA inhibits the progression and metastasis of colorectal cancer.
Supporting Evidence
- PCCA is highly expressed in CRC tumor tissues compared to normal tissues.
- Knocking down PCCA reduced CRC cell migration, invasion, and proliferation.
- PCCA knockdown suppressed CRC tumor growth and lung metastasis.
- Knockdown PCCA increased M1-macrophage polarization.
Takeaway
This study found that reducing a specific gene called PCCA can slow down the growth and spread of colorectal cancer cells.
Methodology
The study used bioinformatics analysis, colorectal tumor tissues, CRC cell lines, and various assays to evaluate PCCA's effects on cancer cell behavior.
Limitations
The study primarily used mouse models and cell lines, which may not fully represent human CRC.
Participant Demographics
Patients who underwent surgery at the Sixth Affiliated Hospital of Sun Yat-sen University.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website